BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20238002)

  • 1. Photoreceptor guanylate cyclases and cGMP phosphodiesterases in zebrafish.
    Collery RF; Kennedy BN
    Adv Exp Med Biol; 2010; 664():55-61. PubMed ID: 20238002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetics of retinal photoreceptor proteins involved in cGMP metabolism.
    Pittler SJ; Baehr W
    Prog Clin Biol Res; 1991; 362():33-66. PubMed ID: 1672236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of cGMP in the vertebrate retina: from the initial research on rd mutant mice to zebrafish genetic approaches.
    Iribarne M; Masai I
    J Neurogenet; 2017 Sep; 31(3):88-101. PubMed ID: 28812418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do cGMP Levels Drive the Speed of Photoreceptor Degeneration?
    Iribarne M; Masai I
    Adv Exp Med Biol; 2018; 1074():327-333. PubMed ID: 29721960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic GMP systems in the retina.
    Ferrendelli JA; De Vries GW
    Fed Proc; 1983 Nov; 42(14):3103-6. PubMed ID: 6138283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic expression of cyclic GMP phosphodiesterase activity defines abnormal photoreceptor differentiation in neurological mutants of inherited retinal degeneration.
    Fletcher RT; Sanyal S; Krishna G; Aguirre G; Chader GJ
    J Neurochem; 1986 Apr; 46(4):1240-5. PubMed ID: 3005510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. shRNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa.
    Tosi J; Davis RJ; Wang NK; Naumann M; Lin CS; Tsang SH
    J Cell Mol Med; 2011 Aug; 15(8):1778-87. PubMed ID: 20950332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic GMP in the retinas of normal mice and those heterozygous for early-onset photoreceptor dystrophy.
    Doshi M; Voaden MJ; Arden GB
    Exp Eye Res; 1985 Jul; 41(1):61-5. PubMed ID: 2863161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal diseases linked with photoreceptor guanylate cyclase.
    Duda T; Koch KW
    Mol Cell Biochem; 2002 Jan; 230(1-2):129-38. PubMed ID: 11952088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.
    Zhang X; Feng Q; Cote RH
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3060-6. PubMed ID: 16123402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase dysfunction, cyclic GMP accumulation, and visual cell degeneration in early-onset inherited blindness.
    Lolley RN; Lee RH
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():315-27. PubMed ID: 6145326
    [No Abstract]   [Full Text] [Related]  

  • 12. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
    Liu J; Timmers AM; Lewin AS; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal degeneration in mice lacking the gamma subunit of the rod cGMP phosphodiesterase.
    Tsang SH; Gouras P; Yamashita CK; Kjeldbye H; Fisher J; Farber DB; Goff SP
    Science; 1996 May; 272(5264):1026-9. PubMed ID: 8638127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cyclic GMP concentration and guanylate cyclase and cyclic GMP phosphodiesterase activities in proestrus rat after treatment with LH.
    Patwardhan VV; Lanthier A
    Horm Metab Res; 1987 Mar; 19(3):136-7. PubMed ID: 2883102
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclic GMP phosphodiesterase and guanylate cyclase activities in rabbit ovaries and the effect of in-vivo stimulation with LH.
    Patwardhan VV; Lanthier A
    J Endocrinol; 1984 Jun; 101(3):305-10. PubMed ID: 6144719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of nitric oxide synthase, soluble guanylyl cyclase, and Ca2+/calmodulin-stimulated cGMP phosphodiesterase as components of neuronal signal transduction.
    Mayer B; Koesling D; Böhme E
    Adv Second Messenger Phosphoprotein Res; 1993; 28():111-9. PubMed ID: 7691122
    [No Abstract]   [Full Text] [Related]  

  • 17. Rods are selectively altered by lead: I. Electrophysiology and biochemistry.
    Fox DA; Farber DB
    Exp Eye Res; 1988 Apr; 46(4):597-611. PubMed ID: 2898378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration.
    Olshevskaya EV; Ermilov AN; Dizhoor AM
    Mol Cell Biochem; 2002 Jan; 230(1-2):139-47. PubMed ID: 11952089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP metabolism and its role in brain physiology.
    Domek-Łopacińska K; Strosznajder JB
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():15-34. PubMed ID: 16077188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants of the PDE6 GAF A domain for binding the inhibitory gamma-subunit and noncatalytic cGMP.
    Muradov H; Boyd KK; Artemyev NO
    Vision Res; 2004; 44(21):2437-44. PubMed ID: 15358079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.